Diplon, Baby Boy .

HRN: 29-25-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/03/2026
07/10/2026
IV
48mg
Q24h
T/C NEONATAL SEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: